维普中文期刊产品整合服务
199篇 您的检索式:作者名="Wadleigh"
    题名 作者 年代 出处 被引量
1Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein 显示文摘Ng CJ Wadleigh DJ Gangopadhyay A 2001J Biol Chem2001,276,44:1
2Human para-oxonase-3 is an HDL-associated enzyme with biological ac-tivity similar to paraoxonase-1 protein but is not regulated by oxidized lipids显示文摘 Wadleigh DJ Grijalva V 2001Arterioscler Thromb Vasc Biol2001,21,4:1
3Activating mutation in the tyrosinc kinase JAK2 in polycythemia vent , essential thrombocythemia and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M 2005Cancer Cell2005,7,4:1
4Lichens and atmospheric sulphur: what stable isotopes reveal 显示文摘Wadleigh MA 2003Environmental Pollution2003,126,:1
5Hepatic veno-occlusive disease:pathogenesis,diagnosis and treatment显示文摘Wadleigh M Ho V Momtaz P 2003Curr Opin Hematol2003,10,6:1
6Classification and diagnosis of myelopmliferative neoplasms according to the 2008 World Health Organization criteria显示文摘Wadleigh M Tefferi A 2010Int J Hematol2010,91,2:1
7Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
8Tracing sources of atmospheric sulphur using epiphytic lichens显示文摘Wadleigh MA Blake DM 1999Environmental Pollution1999,106,:1
9Pacli*axel given by a weekly 1-h infusion in advanced esophageal cancer显示文摘Ilson D H Wadleigh R G Leichman L P 2007AnnOncol2007,18,7:1
10X inactivation based clonality analysis and quantitative JAK2 V617F assessment reveal a strong association between clonality and JAK2 V617F in PV but not ET/MMM, and identifies a subset of JAK2 V617F negative ET and MMM patient s with clonal hematopoiesis显示文摘Levine RL Belisl EC Wadleigh M 2006Blood2006,107,10:1
11Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia,and Myeloid Metaplasia with MycloSibrosis 显示文摘Levine R L Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
12Activating mutation in the tyrosine kinase JAN2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis显示文摘LEVINE R L WADLEIGH M COOLS J 2005Cancer Cell2005,7,:1
13Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
14Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein显示文摘Ng CJ Wadleigh DJ Gangopadhyay A 2001J Biol Chem2001,276,44:1
15Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria显示文摘Wadleigh M Tefferi A 2010Int J Hematol2010,91,2:1
16Classification and diagnosis of myel- opmliferative neoplasms according to the 2008 World Health Organization criteria显示文摘Wadleigh M Tefferi A 2010Int J Hematol2010,91,2:1
17Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘Levine RL Wadleigh M Cools J 0,,4:1
18Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis 显示文摘Levine R L Wadleigh M Cools J 2005Cancer Cell2005,7,4:1
19Acti-vating mutation in the tyrosine kinase JAK2in poly-cythemia vera,essential thrombocythemia,and mye-loid metaplasia with myelofibrosis显示文摘LEVINE R L WADLEIGH M COOLS J 2005Cancer Cell2005,7,:1
20Vitamin E in the treatment of chemotherapy- induced mucositis显示文摘Wadleigh RG Redmen RS Graham ML 1992Am J Med1992,92,:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费